MedPath

Evaluation of a New Bioactive Material Versus a Fluoride-Releasing Hybrid Restorative Material in Cervical Lesions

Not Applicable
Conditions
Dental Caries
Interventions
Procedure: cervical restoration
Registration Number
NCT05149209
Lead Sponsor
Cairo University
Brief Summary

* This study will be conducted to evaluate and compare the clinical performance of fluoride, calcium, and phosphate-releasing new bioactive material versus a fluoride-releasing hybrid restorative material in cervical lesions for one-year follow-up.

* The clinical evaluation will be done using modified USPHS criteria at baseline,3,6,9 and 12 months.

Detailed Description

two groups of 30 patients will receive cervical restorations by using calcium and phosphate releasing hybrid restorative material (Activa™ Presto, Pulpdent®, USA), or a fluoride-releasing hybrid restorative material (Giomer, Shofu, Japan). Then these restorations will be evaluated at baseline, 3 months, 6 months, 9 months, and 12 months according to modified USPHS criteria in terms of marginal adaptation, Marginal discoloration, recurrent caries, retention, surface texture, and Post-operative sensitivity.

* Examination and selection of all patients will be done according to inclusion and exclusion criteria.

* A class v cavity will be prepared after local anesthesia has been given as required. Rubber dam isolation followed by the placement of restorative material according to the randomization sequence.

* For the intervention: selective etching to enamel and universal bond agent to all the cavity will be applied first, followed by filling of the cavity with fluoride, calcium, and phosphate-releasing new bioactive material (Activa™ Presto, Pulpdent®, USA) using a 19-gauge applicator tip on the syringe and light-curing for 20 seconds between each 2mm layer.

* For the control group: selective etching to enamel and universal bond agent to all the cavity will be applied first, followed by filling of the cavity with fluoride-releasing hybrid restorative material (Giomer, Shofu, Japan) and will be light polymerized using a light-emitting diode (LED) light-curing unit for 10 seconds between each 2mm layer.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • a)Inclusion Criteria of participants:

    • Male or female gender.
    • Only co-operative patients will be approved to participate in the trial.
    • Medically free adult patients.
    • The age range of the patients is 18-40 years. b)Inclusion Criteria of teeth:
    • Small to moderate cervical lesion.
    • Vital upper or lower teeth with no signs of irreversible pulpitis.
    • Caries extension shouldn't exceed mesiodistal width and inciso(occluso)-gingival length not exceed incisal (occlusal) one third.
Exclusion Criteria
  • a)Exclusion criteria of participants:

    • Allergic history concerning methacrylates

    • Pregnancy

    • Heavy smoking; xerostomia

    • Lack of compliance

    • Patients with disabilities.

    • Patients having systemic diseases or severe medically compromised.

    • Patients with severe bruxism, clenching, or temporomandibular joint disorders.

      b)Exclusion criteria of the teeth:

    • Deep defects (close to the pulp, less than 1 mm distance).

    • Periapical pathology or signs of pulpal pathology.

    • Possible prosthodontic restoration of teeth.

    • Heavy occlusion and occlusal contacts or history of bruxism.

    • Pulpitis, non-vital or endodontically treated teeth.

    • Sever periodontal affection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fluoride, calcium and phosphate-releasing new bioactive material (Activa™ Presto, Pulpdent®, USA).cervical restorationACTIVA Presto is a novel bioactive material with a mineral-enriched hydrophilic resin base and a patented rubberized component that resists abrasion and wear with high release and recharge of not only fluoride but also calcium and phosphate ions. It doesn't contain BIS-GMA, Bisphenol A, or BPA derivatives.
Fluoride-releasing hybrid restorative material (Giomer, Shofu, Japan).cervical restorationGiomer is a hybrid restorative material that contains a resin base and pre-reacted glass ionomer. S-PRG (surface reaction type) technology provides some properties of GI such as fluoride release and recharge which helps prevent recurrent caries.
Primary Outcome Measures
NameTimeMethod
Marginal adaptationone year

The restoration will be clinically assessed by visual inspection and explorer. Restorations will be given a score using modified USPHS criteria:

Alfa: Closely adapted, no visible crevice Bravo: Visible crevice, the explorer will penetrate Charlie: Crevice in which dentin is exposed

Secondary Outcome Measures
NameTimeMethod
Marginal Discolorationone year

Clinical evaluation by visual inspection and mirror if needed using modified USPHS criteria. Restorations will be given the score:

Alfa if No discoloration Bravo if Non penetrating marginal discoloration which can be polished away Charlie if Discoloration with penetration in pulpal direction.

postoperative sensitivityone year

Verbal evaluation by asking the patient. Restorations will be given a score according to modified USPHS criteria:

Alfa if not present Bravo if sensitive but diminishing in intensity Charlie if constant sensitivity not diminishing.

Retentionone year

Clinical evaluation by visual inspection and explorer. Restorations will be given a score according to modified USPHS criteria :

Alfa if restoration is retained and there is no loss of restoration. Charlie if loss of restoration.

Secondary cariesone year

Clinical evaluation by visual inspection and explorer. Restorations will be given a score according to modified USPHS criteria:

Alfa if no recurrent caries is detected, charlie if recurrent caries is detected.

.

surface textureone year

Clinical evaluation by visual inspection and explorer. Restorations will be given a score according to modified USPHS criteria:

Alfa if restoration is enamel-like surface Bravo if Surface rougher than enamel, clinically acceptable Charlie if Surface is unacceptably rough.

Trial Locations

Locations (1)

Nourhan Khaled Mohamed Samir

🇪🇬

Cairo, Maadi, Egypt

© Copyright 2025. All Rights Reserved by MedPath